UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035781
Receipt number R000040696
Scientific Title A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer
Date of disclosure of the study information 2019/02/15
Last modified on 2019/02/15 00:28:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer

Acronym

RATE for TEC

Scientific Title

A randomized phase II study of robot-assisted thoracoscopic versus thoracoscopic esophagectomy for patients with curative surgery for thoracic esophageal cancer

Scientific Title:Acronym

RATE for TEC

Region

Japan


Condition

Condition

Thoracic esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the safety of robot assisted thoracoscopic esophagectomy compared with thoracoscopic esophagectomy.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Incidence of Grade I or more postoperative recurrent nerve paralysis in Clavien-Dindo classification

Key secondary outcomes

1) Grade II and more total complications in Clavien-Dindo classification, 2) Operation time, 3) Blood loss, 4) Number of dissected mediastinum lymph node, 5) Change of surgical method, 6) Intraoperative adverse event, 7) Postoperative hospital stay , 8) QOL score (EORTC QLQ-C30, EORTC QLQ-OES18, EQ-5D-5L), 9) Operation related death, 10) Recurrent free survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Thoracoscopic esophagectomy for thoracic esophageal cancer

Interventions/Control_2

Robot assisted thoracoscopic esophagectomy for thoracic esophageal cancer

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Primary lesions are all confined within the thoracic esophagus, 2) an esophageal epithelial malignancy, 3) Clinical stage I,II,III(excluding T4), UICC-TNM 8th, 4) Surgery approached from the neck, chest and abdomen (R0 resection) with D2 dissection followed by gastric conduit reconstruction, 5) >20 and <80 y.o., 6) ECOG-PS 0 or 1, 7) BMI >17 and <30, 8) No history of surgery for esophageal cancer, 9 ) No history of chemotherapy or radiotherapy, 10) No history of right thoracotomy or left lung lobectomy, 11) FEV1.0 >1.0L, 12) a) WBC >2000 and <10000/mm3, b) PLT >50000/mm3, c) Hb >10.0 g/dl, d) AST <100 IU/L, ALT <100IU/L, e) T-Bil <2.0 g/dl, f) Cre <1.5mg/dl, g) SpO2 >95%, 13) Written consent

Key exclusion criteria

1) Excision of other organs excluding gall bladder, 2) Active double cancer, 3) Pregnancy or breast-feeding, 4) Psychosis or mental symptoms, 5) Systemic administration of steroids, 6) History of myocardial infarction or unstable angina, 7) Poorly controlled hypertension, 8) Poorly controlled diabetes, 9) Respiratory disease requiring sustained oxygen therapy.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Kamei

Organization

Tohoku University Hospital

Division name

Department of Surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN

TEL

022-717-7214

Email

tkamei@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Okamoto

Organization

Tohoku University Hospital

Division name

Department of Surgery

Zip code


Address

1-1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, JAPAN

TEL

022-717-7214

Homepage URL


Email

hi-ok-0531@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Hospital

Institute

Department

Personal name



Funding Source

Organization

University grants of Tohoku University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院(宮城県)


Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 01 Month 29 Day

Date of IRB


Anticipated trial start date

2019 Year 03 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 05 Day

Last modified on

2019 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040696


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name